Stock Track | Biohaven Pharmaceutical Plunges 6.69% in Pre-Market After BofA Lowers Price Target

Stock Track03-03

Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant pre-market plunge of 6.69% on Tuesday, following analyst actions from Bank of America.

The sharp decline came after BofA analyst Jason Gerberry lowered the firm's price target on Biohaven to $14 from $15 while maintaining a Neutral rating on the shares. This price target reduction represents a downward revision in the bank's valuation outlook for the pharmaceutical company.

Bank of America Securities had previously reiterated a Hold rating on Biohaven Ltd., with the latest adjustment indicating a more cautious stance on the stock's near-term prospects. Analyst price target reductions often trigger negative market reactions as investors reassess their valuation expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182010133?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 22:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182010133","market":"nz","top_or_hot":-1,"title":"Stock Track | Biohaven Pharmaceutical Plunges 6.69% in Pre-Market After BofA Lowers Price Target","media":"Stock Track","content":"<p>Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant pre-market plunge of 6.69% on Tuesday, following analyst actions from Bank of America.</p><p>The sharp decline came after BofA analyst Jason Gerberry lowered the firm's price target on Biohaven to $14 from $15 while maintaining a Neutral rating on the shares. This price target reduction represents a downward revision in the bank's valuation outlook for the pharmaceutical company.</p><p>Bank of America Securities had previously reiterated a Hold rating on Biohaven Ltd., with the latest adjustment indicating a more cautious stance on the stock's near-term prospects. Analyst price target reductions often trigger negative market reactions as investors reassess their valuation expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Biohaven Pharmaceutical Plunges 6.69% in Pre-Market After BofA Lowers Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Biohaven Pharmaceutical Plunges 6.69% in Pre-Market After BofA Lowers Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-03 22:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant pre-market plunge of 6.69% on Tuesday, following analyst actions from Bank of America.</p><p>The sharp decline came after BofA analyst Jason Gerberry lowered the firm's price target on Biohaven to $14 from $15 while maintaining a Neutral rating on the shares. This price target reduction represents a downward revision in the bank's valuation outlook for the pharmaceutical company.</p><p>Bank of America Securities had previously reiterated a Hold rating on Biohaven Ltd., with the latest adjustment indicating a more cautious stance on the stock's near-term prospects. Analyst price target reductions often trigger negative market reactions as investors reassess their valuation expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHVN","symbol_name":"Biohaven Pharmaceutical Holding Co Ltd.","start_time":0,"source_url":"","article_id":"1182010133","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182010133","pubTimestamp":1772546805,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant pre-market plunge of 6.69% on Tuesday, following analyst actions from Bank of America.The sharp decline came after BofA...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BHVN":"Biohaven Pharmaceutical Holding Co Ltd."},"translate_title":"个股追踪|美银下调目标价后Biohaven Pharmaceutical盘前暴跌6.69%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHVN":1},"content_text":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant pre-market plunge of 6.69% on Tuesday, following analyst actions from Bank of America.The sharp decline came after BofA analyst Jason Gerberry lowered the firm's price target on Biohaven to $14 from $15 while maintaining a Neutral rating on the shares. This price target reduction represents a downward revision in the bank's valuation outlook for the pharmaceutical company.Bank of America Securities had previously reiterated a Hold rating on Biohaven Ltd., with the latest adjustment indicating a more cautious stance on the stock's near-term prospects. Analyst price target reductions often trigger negative market reactions as investors reassess their valuation expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182010133","isCrawlerRequest":true}